difference, FEV 1 forced expiratory volume in 1 s, FVC forced vital capacity aAdjusted for smoking, childhood secondhand smoke, wood, charcoal, or kerosene fuel use in childhood home, occupational air pollution, and education Table 3 Exposure response between early-life arsenic and lung function residuals (observed minus predicted) and percent of age-, sex-, and height-predicted {Selleck Anti-diabetic Compound Library|Selleck Antidiabetic Compound Library|Selleck Anti-diabetic Compound Library|Selleck Antidiabetic Compound Library|Selleckchem Anti-diabetic Compound Library|Selleckchem Antidiabetic Compound Library|Selleckchem Anti-diabetic Compound Library|Selleckchem Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|buy Anti-diabetic Compound Library|Anti-diabetic Compound Library ic50|Anti-diabetic Compound Library price|Anti-diabetic Compound Library cost|Anti-diabetic Compound Library solubility dmso|Anti-diabetic Compound Library purchase|Anti-diabetic Compound Library manufacturer|Anti-diabetic Compound Library research buy|Anti-diabetic Compound Library order|Anti-diabetic Compound Library mouse|Anti-diabetic Compound Library chemical structure|Anti-diabetic Compound Library mw|Anti-diabetic Compound Library molecular weight|Anti-diabetic Compound Library datasheet|Anti-diabetic Compound Library supplier|Anti-diabetic Compound Library in vitro|Anti-diabetic Compound Library cell line|Anti-diabetic Compound Library concentration|Anti-diabetic Compound Library nmr|Anti-diabetic Compound Library in vivo|Anti-diabetic Compound Library clinical trial|Anti-diabetic Compound Library cell assay|Anti-diabetic Compound Library screening|Anti-diabetic Compound Library high throughput|buy Antidiabetic Compound Library|Antidiabetic Compound Library ic50|Antidiabetic Compound Library price|Antidiabetic Compound Library cost|Antidiabetic Compound Library solubility dmso|Antidiabetic Compound Library purchase|Antidiabetic Compound Library manufacturer|Antidiabetic Compound Library research buy|Antidiabetic Compound Library order|Antidiabetic Compound Library chemical structure|Antidiabetic Compound Library datasheet|Antidiabetic Compound Library supplier|Antidiabetic Compound Library in vitro|Antidiabetic Compound Library cell line|Antidiabetic Compound Library concentration|Antidiabetic Compound Library clinical trial|Antidiabetic Compound Library cell assay|Antidiabetic Compound Library screening|Antidiabetic Compound Library high throughput|Anti-diabetic Compound high throughput screening| values (mean ± SD)  

Peak arsenic before age 10 <50 μg/l (n = 45) 50–250 μg/l (n = 20) >800 μg/l (n = 32) Percent predicted FEV1 98.2 ± 14.6 91.2 ± 11.0 88.1 ± 18.3 Percent predicted FVC 103.6 ± 16.7 98.2 ± 10.0 94.7 ± 15.3 FEV1 residual (ml) −63 ± 443 −270 ± 314 −375 ± 611 FVC residual (ml) 103 ± 584 −54 ± 380 −226 ± 614   50–250 compared to <50 μg/l learn more >800 compared to <50 μg/l P trendb Smoothened inhibitor Crude Adjusteda Crude Adjusteda Crude Adjusteda Diff. P value Diff. P value Diff. P value Diff. P value Percent predicted FEV1 −7.0 0.03 −4.6 0.18 −10.0 0.005 −11.5 0.04 0.005 0.03 Percent predicted FVC −5.3 0.10 −2.7 0.32 −8.8 0.01 −12.2 0.04 0.008 0.03 FEV1 residual (ml) −208 0.03 −152 0.16 −312 0.006 −335 0.06 0.005 0.03 FVC residual (ml) −157 0.14 −52 0.40 −329 0.01 −429 0.04 0.006 0.02

Diff. difference, FEV 1 forced expiratory volume in 1 s, FVC forced vital capacity aAdjusted for smoking, childhood secondhand

smoke, wood, charcoal, or kerosene fuel use in childhood home, occupational air pollution, and education bHighest known arsenic concentration before age 10 was entered as a continuous variable in linear models Table 4 Prevalence odds ratios (PORs) and 95% confidence intervals (CIs) for respiratory symptoms   Peak arsenic before age 10 Crude Adjusteda 0–250 μg/l (n = 65) > 800μg/l (n = 32) POR 95% CI P value POR 95% CI P value Chronic cough 7 (11%) 5 (16%) 1.53 0.45–5.28 0.26 1.30 0.22–7.80 0.39 Chronic phlegm 5 (7%) 2 (6%) 0.80 0.15–4.37 0.38 0.93 0.10–9.01 0.48 Chronic bronchitis 2 (3%) 1 (3%) 1.02 0.09–11.6 0.49 N/A N/A N/A Trouble breathing Bay 11-7085  Rarely 16 (25%) 4 (13%) 0.44 0.13–1.44 0.08 1.20 0.25–5.73 0.41  Often 2 (3%) 2 (6%) 2.10 0.28–15.6 0.23 1.01 0.06–17.2 0.49 Breathlessness walking  Fast/uphill 15 (23%) 13 (41%) 2.28 0.92–5.67 0.04 2.53 0.68–9.45 0.08  At group pace 9 (14%) 12 (38%) 3.73 1.37–10.2 0.004 5.94 1.36–26.0 0.009  At own pace 7 (11%) 10 (31%) 3.77 1.27–11.1 0.006 3.89 0.90–16.8 0.03 Any respiratory symptom 20 (31%) 14 (44%) 1.75 0.73–4.20 0.11 2.63 0.78–8.92 0.06 N/A not available (adjustment variables missing for 1 “yes” respondent) aAdjusted for age, sex, smoking, childhood secondhand smoke, wood, charcoal, or kerosene fuel use in childhood home, occupational air pollution, and education Table 2 shows lung function mean residuals (observed minus predicted) and percent of age-, sex-, and height-predicted values.